Emergent biosolutions stock price
WebFeb 16, 2024 · Emergent Biosolutions EBS shares ended the last trading session 12.5% higher at $14.92. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ... WebApr 12, 2024 · Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently up 19.59% so far this month. During the month of April, Emergent Biosolutions Inc’s stock price has reached a high of $13.67 and a low of $9.47. Over the last year, Emergent Biosolutions Inc has hit prices as high as $43.33 and as low as …
Emergent biosolutions stock price
Did you know?
WebApr 10, 2024 · View Emergent Biosolutions Inc EBS investment & stock information. Get the latest Emergent Biosolutions Inc EBS detailed stock quotes, stock data, Real … WebApr 6, 2024 · Emergent BioSolutions Inc. (EBS) Stock Price Today, Quote & News Seeking Alpha EBS Emergent BioSolutions Inc. Stock Price & Overview 10.3K …
WebApr 10, 2024 · Today was huge for biotech stock Emergent BioSolutions as its stock blasted up nearly 18% at the time of writing thanks to positive words from Benchmark.Benchmark believes there’s a lot of upside potential afoot for Emergent, potentially up to double current share prices. Word from Benchmark analyst Robert … WebEmergent BioSolutions Stock Rises 17% on FDA Narcan Approval Mar. 29, 2024 at 9:09 a.m. ET Emergent Biosolutions downgraded to underweight from neutral at J.P. …
WebView the latest Emergent Biosolutions Inc. (EBS) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebThe latest closing stock price for Emergent Biosolutions as of March 15, 2024 is 9.65. The all-time high Emergent Biosolutions stock closing price was 134.94 on August 13, 2024. The Emergent Biosolutions 52-week high stock price is 45.14, which is 367.8% above the current share price.
WebEBS: Raising target price to $8.00 EMERGENT BIOSOLUTIONS INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Low; a... See the company profile for Emergent BioSolutions Inc. (EBS) including … See Emergent BioSolutions Inc. (EBS) stock analyst estimates, including … Find out the direct holders, institutional holders and mutual fund holders for … Get the detailed quarterly/annual income statement for Emergent BioSolutions … Emergent Biosolutions (EBS) was a big mover last session on higher-than … Find the latest Emergent BioSolutions Inc. (EBS) stock quote, history, news and … Find the latest Emergent BioSolutions Inc. (EBS) stock quote, history, news and … Emergent BioSolutions Reports Financial Results for Fourth Quarter 2024. … Stocks sink after Fed minutes despite cooler inflation: Stock market news …
WebSep 24, 2024 · The stock price of Emergent Biosolutions, a specialty biopharmaceutical company, has seen a fall of 15% over the last twenty-one trading days, while it is down 42% year-t0-date. EBS stock has had ... calendario community manager 2023 chileWebApr 6, 2024 · The 9 analysts offering price forecasts for Emergent BioSolutions have a median target of 61.44, with a high estimate of 150.00 and a low estimate of 9.00. The … coach hampton patchwork purseWebWhat happened to Emergent Biosolutions’s price movement after its last earnings report? Emergent Biosolutions reported an EPS of -$0.31 in its last earnings report, missing … calendario di windows 11WebFeb 28, 2024 · Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 6.14% so far this month. During the month of February, Emergent Biosolutions Inc’s stock price has reached a high of $16.66 and a low of $11.63. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 … coach hampton lunch toteWebApr 12, 2024 · As of April 12, 2024, Emergent Biosolutions Inc’s stock price is $12.39, which is down 6.21% from its previous closing price. At AAII, we stress that investors … calendario di windows 10WebApr 12, 2024 · Emergent BioSolutions (NYSE:EBS – Get Rating) was upgraded by analysts at Benchmark from a “hold” rating to a “buy” rating in a note issued to investors on Monday, The Fly reports.The firm currently has a $22.00 price objective on the biopharmaceutical company’s stock. Benchmark’s price target indicates a potential … coach hamishWebApr 10, 2024 · According to analysts' consensus price target of $31.20, Emergent BioSolutions has a forecasted upside of 201.2% from its current price of $10.36. … calendario de adviento the body shop